Preparing for a U.S. FDA Audit

Instructor: John E Lincoln
Product ID: 700816
  • Duration: 60 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD

One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-963-2556


Read Frequently Asked Questions

How to create and blend the Risk Management File findings into the company’s internal and external audit plans?

Structured, defined and tested CGMP systems are the start in successfully passing the "real thing". Increasingly such systems are to be risk-based, as stated by the US FDA and the EU. So, where does a company look to ensure their compliance is structured and prioritized by risk? How to create and blend the Risk Management File findings into the company’s internal and external audit plans? How is it established, maintained, formally updated, and documented? Learn from others mistakes - current FDA 483 observations. The receptionist - an auditor’s first company contact. Strategic perception. Arrangements for and facilitation of the outside audit. Training personnel on how to be "audited". Close outs "musts". Where and how to draw the "line in the sand". Responses - how, what, frequency. Avoiding Warning Letters.

Areas Covered in the seminar:

  • Recent regulatory expectations.
  • The Company CGMP Compliance Audit Plan.
  • Most commonly missed internal audit areas.
  • How to use your Risk Management Tools (per Q9 and ISO 14971)?
  • Risk by 21 CFR categories; ISO 13485; ISO 9001.
  • Using the FDA’s QSIT for analysis of QMS audit’s high risk concerns.
  • Design control / change control expectations.
  • CAPA - a major source of potential mine fields.
  • P&PC and what is "auditable quality data".
  • Management reviews; fine-tune and get credit action taken.

Who will benefit:

  • Senior Management.
  • Project Leaders
  • Internal/External Consultants.
  • Regulatory affairs.
  • Quality systems personnel.
  • All charged with implementing, administering and supporting the QMS (Quality Management System), including new product development, regulatory submissions, initiating / overseeing company-wide quality management / planning.
  • CAPA, P&PC and training personnel.
  • All who are or could be a member of a CGMP Internal Audit Team.

Instructor Profile:

John E. Lincoln, consultant, has successfully designed, written and run all types of qualifications/validations, which have passed FDA audit or submission scrutiny, and described in peer-reviewed technical articles and workshops, world wide. John has also managed pilot production, regulatory affairs, product development/design control, 510(k) submissions, risk management per ISO 14971, and projects; with over 27 years of experience, primarily in the medical device industry.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
21 CFR Part 11 Compliance for SaaS/Cloud Applications - 80202SEM

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed